The placebo effect in allergen-specific immunotherapy trials

BACKGROUND: Double-blind, placebo-controlled (DBPC) trials are the gold standard for demonstrating clinical efficacy and tolerability. The placebo effect, although an important feature in placebo-controlled studies, has never been systematically investigated in allergen-specific immunotherapy (SIT)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Narkus, Annemie, Lehnigk, Ulrike, Haefner, Dietrich, Klinger, Regine, Pfaar, Oliver, Worm, Margitta
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878370/
https://ncbi.nlm.nih.gov/pubmed/24360060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-7022-3-42
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki